{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T08:12:57Z","timestamp":1688199177251},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T00:00:00Z","timestamp":1366761600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/ja.2013.29","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T06:18:09Z","timestamp":1366784289000},"page":"495-497","source":"Crossref","is-referenced-by-count":3,"title":["In vitro susceptibilities of clinical isolates of Escherichia coli and Klebsiella species to CSE1034 and other \u03b2-lactams"],"prefix":"10.1038","volume":"66","author":[{"given":"Manu","family":"Chaudhary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anurag","family":"Payasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,24]]},"reference":[{"key":"BFja201329_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","volume":"18","author":"DL Paterson","year":"2005","unstructured":"Paterson, D. L. & Bonomo, R. A. Extended-spectrum \u03b2-lactamases: a clinical update. Clin. Microbiol. Rev. 18, 657\u2013686 (2005).","journal-title":"Clin. Microbiol. Rev."},{"key":"BFja201329_CR2","doi-asserted-by":"publisher","first-page":"R113","DOI":"10.1186\/cc9062","volume":"14","author":"E Meyer","year":"2010","unstructured":"Meyer, E., Schwab, F., Schroeren-Boersch, B. & Gastmeier, P. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Crit. Care 14, R113 (2010).","journal-title":"Crit. Care"},{"key":"BFja201329_CR3","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1099\/jmm.0.036483-0","volume":"61","author":"F Hu","year":"2012","unstructured":"Hu, F. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai, China. J. Med. Microbiol. 61, 132\u2013136 (2012).","journal-title":"J. Med. Microbiol."},{"key":"BFja201329_CR4","first-page":"366","volume":"3","author":"A Payasi","year":"2011","unstructured":"Payasi, A., Kumar, S. & Chaudhary, M. A comparative study of sulbactomax versus ceftriaxone and beta-lactamase inhibitor and their effect on mutant prevention in ESBL producing organisms. Int. J. Drug Dev. Res. 3, 366\u2013371 (2011).","journal-title":"Int. J. Drug Dev. Res."},{"key":"BFja201329_CR5","first-page":"138","volume":"4","author":"M Chaudhary","year":"2012","unstructured":"Chaudhary, M. & Payasi, A. Comparative efficacy of antibiotics in biofilms eradication formed by ESBL and non ESBL producing micro-organisms. Int. J. Drug Dev. Res. 4, 138\u2013147 (2012).","journal-title":"Int. J. Drug Dev. Res."},{"key":"BFja201329_CR6","volume-title":"Bergey\u2019s Manual of Determinative Bacteriology","author":"DH Bergey","year":"1975","unstructured":"Bergey, D. H., Buchanan, R. E. & Gibbons, N. E. Bergey\u2019s Manual of Determinative Bacteriology, Williams & Wilkins Co.: Baltimore, MD, USA, (1975)."},{"key":"BFja201329_CR7","unstructured":"Clinical and Laboratory Standards Institute (CLSI). (Performance Standards for Antimicrobial Susceptibility Testing, Approved Standards CLSI M100-S20, Wayne, PA: USA (2010)."},{"key":"BFja201329_CR8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7883\/yoken.64.249","volume":"64","author":"M Hussain","year":"2011","unstructured":"Hussain, M. et al. Prevalence of class A and AmpC beta-lactamases in clinical Escherichia coli isolates from Pakistan Institute of Medical Science, Islamabad, Pakistan. Jpn. J. Infect. Dis. 64, 249\u2013252 (2011).","journal-title":"Jpn. J. Infect. Dis."},{"key":"BFja201329_CR9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.diagmicrobio.2010.12.002","volume":"70","author":"L Poirela","year":"2011","unstructured":"Poirela, L., Walsh, T. R., Cuvilliera, V. & Nordmanna, P. Multiplex PCR for detection of acquired carbapenemase genes. Diag. Microbiol. Infect. Dis. 70, 119\u2013123 (2011).","journal-title":"Diag. Microbiol. Infect. Dis."},{"key":"BFja201329_CR10","first-page":"332","volume":"132","author":"J Sharma","year":"2010","unstructured":"Sharma, J., Sharma, M. & Ray, P. Detection of TEM & SHV genes in Escherichia coli & Klebsiella pneumoniae isolates in a tertiary care hospital from India. Indian J. Med. Res. 132, 332\u2013336 (2010).","journal-title":"Indian J. Med. Res."},{"key":"BFja201329_CR11","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/ja.2012.82","volume":"65","author":"M Chaudhary","year":"2012","unstructured":"Chaudhary, M. & Payasi, A. Role of EDTA and CSE1034 in curli formation and biofilm eradication of Klebsiella pneumoniae: a comparison with other drugs. J. Antibiotics 65, 631\u2013633 (2012).","journal-title":"J. Antibiotics"},{"key":"BFja201329_CR12","first-page":"72","volume":"4","author":"M Chaudhary","year":"2012","unstructured":"Chaudhary, M., Sudaroli, M., Kumar, S. & Krishnai, R. Catering ESBL resistance challenge through strategic combination of ceftriaxone, sulbactam and ethylenediaminetetraacetic acid. Int. J. Drug Dev. Res. 4, 72\u201381 (2012).","journal-title":"Int. J. Drug Dev. Res."},{"key":"BFja201329_CR13","first-page":"126","volume":"4","author":"M Chaudhary","year":"2012","unstructured":"Chaudhary, M., Kumar, S. & Payasi, A. A novel approach to combat acquired multiple resistance in Escherichia coli by using EDTA as efflux pump inhibitor. J. Microb. Biotech. 4, 126\u2013130 (2012).","journal-title":"J. Microb. Biotech."},{"key":"BFja201329_CR14","doi-asserted-by":"publisher","first-page":"108","DOI":"10.4172\/2161-1459.1000108","volume":"2","author":"VK Dwivedi","year":"2012","unstructured":"Dwivedi, V. K., Kumar, P. & Chaudhary, M. Comparative study of CSE1034 and ceftriaxone in pneumonia induced rat. Clin. Exp. Pharmacol. 2, 108 (2012).","journal-title":"Clin. Exp. Pharmacol."},{"key":"BFja201329_CR15","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4172\/2157-7609.1000130","volume":"3","author":"VK Dwivedi","year":"2012","unstructured":"Dwivedi, V. K., Bhatnagar, A. & Chaudhary, M. Prevention of cadmium toxicity by ceftriaxone plus sulbactam with VRP1034 in rats. J. Drug Metab. Toxicol. 3, 5 (2012).","journal-title":"J. Drug Metab. Toxicol."}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ja201329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201329","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ja201329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T07:37:17Z","timestamp":1688197037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ja201329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,24]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFja201329"],"URL":"https:\/\/doi.org\/10.1038\/ja.2013.29","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,24]]}}}